7-MethoxycoumarinCAS# 531-59-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 531-59-9 | SDF | Download SDF |
PubChem ID | 10748 | Appearance | Cryst. |
Formula | C10H8O3 | M.Wt | 176.2 |
Type of Compound | Coumarins | Storage | Desiccate at -20°C |
Synonyms | Ayapanin; Herniarin; Methylumbelliferone; Umbelliferone methyl ether | ||
Solubility | DMSO : ≥ 125 mg/mL (709.54 mM) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | 7-methoxychromen-2-one | ||
SMILES | COC1=CC2=C(C=C1)C=CC(=O)O2 | ||
Standard InChIKey | LIIALPBMIOVAHH-UHFFFAOYSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 7-Methoxycoumarin, also known as Herniarin, has potent antioxidant, hepatoprotective, and antitumor effects. 7-Methoxycoumarin has a weak estrogenic activity in vitro and in vivo, it could be beneficial with regard to vagina dryness as it showed a tissue specific effect without exposing the uterus to a potential tumorigenic growth. |
Targets | SOD | Estrogen receptor | Progestogen receptor |
In vitro | Inactivation of plant-pathogenic fungus Colletotrichum acutatum with natural plant-produced photosensitizers under solar radiation.[Pubmed: 27434699 ]J Photochem Photobiol B. 2016 Sep;162:402-11.The increasing tolerance to currently used fungicides and the need for environmentally friendly antimicrobial approaches have stimulated the development of novel strategies to control plant-pathogenic fungi such as antimicrobial phototreatment (APT). |
In vivo | Estrogen-like and tissue-selective effects of 7-methoxycoumarin from Ficus umbellata (Moraceae): an in vitro and in vivo study.[Pubmed: 28768532]BMC Complement Altern Med. 2017 Aug 2;17(1):383.Ficus umbellata is a medicinal plant previously shown to endow estrogenic properties. Its major component was isolated and characterized as 7-Methoxycoumarin (MC). Noteworthy, coumarins and the respective active metabolite 7-hydroxycoumarin analogs have shown aromatase inhibitory activity, which is of particular interest in the treatment of estrogen-dependent cancers. The present work aimed at evaluating the estrogenic/antiestrogenic effects of MC in vitro and in vivo. |
Animal Research | Ameliorative effects of 7-methylcoumarin and 7-methoxycoumarin against CCl4-induced hepatotoxicity in rats.[Pubmed: 23126493 ]Drug Chem Toxicol. 2013 Jan;36(1):42-7.This article explores the hepatoprotective and antioxidant potential of 7-methylcoumarin (MC) and 7-Methoxycoumarin (MOC) in CCl(4)-induced hepatotoxicity in rats. |
7-Methoxycoumarin Dilution Calculator
7-Methoxycoumarin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5.6754 mL | 28.3768 mL | 56.7537 mL | 113.5074 mL | 141.8842 mL |
5 mM | 1.1351 mL | 5.6754 mL | 11.3507 mL | 22.7015 mL | 28.3768 mL |
10 mM | 0.5675 mL | 2.8377 mL | 5.6754 mL | 11.3507 mL | 14.1884 mL |
50 mM | 0.1135 mL | 0.5675 mL | 1.1351 mL | 2.2701 mL | 2.8377 mL |
100 mM | 0.0568 mL | 0.2838 mL | 0.5675 mL | 1.1351 mL | 1.4188 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Scopolin
Catalog No.:BCN5701
CAS No.:531-44-2
- Coniferin
Catalog No.:BCN5700
CAS No.:531-29-3
- Androsin
Catalog No.:BCN3842
CAS No.:531-28-2
- Dichotomin
Catalog No.:BCN2836
CAS No.:53093-47-3
- 9,13-Epidioxy-8(14)-abieten-18-oic acid
Catalog No.:BCN1426
CAS No.:5309-35-3
- Morellic acid
Catalog No.:BCN3073
CAS No.:5304-71-2
- Scutebarbatine J
Catalog No.:BCN8134
CAS No.:960302-85-6
- T-5224
Catalog No.:BCC5383
CAS No.:530141-72-1
- Murralongin
Catalog No.:BCN5696
CAS No.:53011-72-6
- Salinomycin
Catalog No.:BCC1916
CAS No.:53003-10-4
- CDI (1,1′-Carbonyldiimidazole)
Catalog No.:BCC2809
CAS No.:530-62-1
- Sinapic acid
Catalog No.:BCN3539
CAS No.:530-59-6
- Esculin
Catalog No.:BCN5904
CAS No.:531-75-9
- Coumarin-3-Carboxylic Acid
Catalog No.:BCC9220
CAS No.:531-81-7
- 4',7-Isoflavandiol
Catalog No.:BCN2855
CAS No.:531-95-3
- Boc-Pyr-OH
Catalog No.:BCC3329
CAS No.:53100-44-0
- Rapamycin (Sirolimus)
Catalog No.:BCC3592
CAS No.:53123-88-9
- Buprenorphine hydrochloride
Catalog No.:BCC5215
CAS No.:53152-21-9
- Euscaphic acid
Catalog No.:BCN5702
CAS No.:53155-25-2
- Delphinidin-3-sambubioside chloride
Catalog No.:BCN3148
CAS No.:53158-73-9
- Acemetacin
Catalog No.:BCC4424
CAS No.:53164-05-9
- Pirfenidone
Catalog No.:BCC5086
CAS No.:53179-13-8
- 6-Aminoindole
Catalog No.:BCC8763
CAS No.:5318-27-4
- Fagomine
Catalog No.:BCC1569
CAS No.:53185-12-9
Estrogen-like and tissue-selective effects of 7-methoxycoumarin from Ficus umbellata (Moraceae): an in vitro and in vivo study.[Pubmed:28768532]
BMC Complement Altern Med. 2017 Aug 2;17(1):383.
BACKGROUND: Ficus umbellata is a medicinal plant previously shown to endow estrogenic properties. Its major component was isolated and characterized as 7-Methoxycoumarin (MC). Noteworthy, coumarins and the respective active metabolite 7-hydroxycoumarin analogs have shown aromatase inhibitory activity, which is of particular interest in the treatment of estrogen-dependent cancers. The present work aimed at evaluating the estrogenic/antiestrogenic effects of MC in vitro and in vivo. METHODS: To do so, in vitro assays using E-screen and reporter gene were done. In vivo, a 3-day uterotrophic assay followed by a postmenopausal-like rat model to characterize MC as well as F. umbellata aqueous extract in ovariectomized Wistar rats was performed. The investigations focused on histological (vaginal and uterine epithelial height) and morphological (uterine wet weight, vagina stratification and cornification) endpoints, bone mass, biochemical parameters and lipid profile. RESULTS: MC induced a significant (p < 0.05) MCF-7 cell proliferation at a concentration of 0.1 muM, but did not inhibit the effect induced by estradiol in both E-screen and reporter gene assays. In vivo, MC treatment did not show an uterotrophic effect in both rat models used. However, MC (1 mg/kg) induced a significant increase (p < 0.01) of vaginal epithelial height. No significant change was observed with MC in abdominal fat weight, serum lipid levels and bone weight. CONCLUSION: These results suggest that MC has a weak estrogenic activity in vitro and in vivo that accounts only in part to the estrogenicity of the whole plant extract. MC could be beneficial with regard to vagina dryness as it showed a tissue specific effect without exposing the uterus to a potential tumorigenic growth.
Ameliorative effects of 7-methylcoumarin and 7-methoxycoumarin against CCl4-induced hepatotoxicity in rats.[Pubmed:23126493]
Drug Chem Toxicol. 2013 Jan;36(1):42-7.
The available conventional remedies for the treatment of drug-induced liver diseases are highly inadequate and possess serious adverse effects; therefore, the development of new, effective drugs is considered necessary. This article explores the hepatoprotective and antioxidant potential of 7-methylcoumarin (MC) and 7-Methoxycoumarin (MOC) in CCl(4)-induced hepatotoxicity in rats. MC and MOC individually, at doses of 50 and 100 mg/kg body weight, were administered orally once-daily for 7 days. The hepatoprotective activity was assessed using various biochemical parameters, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), serum bilirubin (TB), total protein (TP), and albumin (TA). Serum antioxidant enzyme [e.g., superoxide dismutase (SOD) and catalase (CAT)] levels were determined. Also, thiobarbituric-acid-related substances (TBARS) levels, along with histopathological studies of liver tissue, were scrutinized. Pretreatment with MC and MOC significantly decreased ALT, AST, and TB in the serum of CCl(4)-induced liver damaged rats in a dose-dependent manner. TA and TP levels in the serum were also restored significantly in all presupplemented MC and MOC groups. In addition, oxidative stress induced by CCl(4) was prevented significantly; thereby, increasing SOD and CAT levels and decreasing TBARS levels in liver homogenates. Histopathological studies revealed the ameliorative natures of both the compounds. This study demonstrates the strong hepatoprotective activity of MC and MOC, which could be attributed to their potent antioxidant effects.